Y0002117

Tetracain

European Pharmacopoeia (EP) Reference Standard

• Synonym(e): 4-(Butylamino)-benzoesäure-2-(dimethylamino)-ethylester
• Empirische Formel (Hill-System): C₁₅H₂₄N₂O₂
• CAS-Nummer: 94-24-6
• Molekulargewicht: 264.36
• MDL-Nummer: MFCD00053787
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• API-Familie: tetracaine
• Hersteller/Markenname: EDQM
• Lagertemp.: 2-8°C
• SMILES String: CCCCNc1ccc(cc1)C(=O)OCCN(C)C
• InChI: 1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3
• InChIKey: GKCBAIGFKIBETG-UHFFFAOYSA-N
• Angaben zum Gen: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Topisches Augenanästhetikum; angewendet bei Rückenmarkanästhesie

Biochem./physiol. Wirkung

Hemmt spannungsempfindliche Freisetzung von Ca²⁺ aus sarkoplasmatischem Retikulum.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H301,H317,H351
• P-Sätze: P201 - P280 - P301 + P310 + P330 - P302 + P352
• Gefahreneinstufungen: Acute Tox. 3 Oral - Carc. 2 - Skin Sens. 1
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable